Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)

Te­va of­fi­cial­ly shut­ters the doors to a trou­bled South­ern Cal­i­for­nia site

While FDA in­ves­ti­ga­tors ear­li­er this year found is­sues at Te­va Phar­ma­ceu­ti­cals’ plant in Irvine, CA, forc­ing the com­pa­ny to pad­lock the doors, the com­pa­ny has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.